Biomarkers of Habitual Short Sleep and Related Cardiometabolic Risk

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The overall goal is to determine how a sleep extension intervention (increasing time in bed) in individuals who maintain less than 6.5 hours sleep per night affects their plasma ceramides and insulin sensitivity. Participants will undergo a randomized controlled trial, with sleep extension (intervention) and healthy lifestyle (control) groups. The sleep extension is designed to increase participant's time in bed by 2 hours per night. Alternatively, the control group will receive basic health information (e.g., physical activity, goal setting, and nutrition when eating out).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:

• Age: 18-45 years old; equal numbers of men and women

• Body mass index (BMI): 27.5-34.9 kg/m2

• Sleep Habits: habitual self-reported average total sleep time (TST) \<6.5 hours per night for prior 6 months

Locations
United States
Utah
College of Health Research Complex--University of Utah
RECRUITING
Salt Lake City
Contact Information
Primary
Christopher M Depner, PhD
christopher.depner@utah.edu
801-581-2275
Time Frame
Start Date: 2024-02-12
Estimated Completion Date: 2028-01
Participants
Target number of participants: 70
Treatments
No_intervention: Control Group
Provided with general health information on diet and physical activity.
Experimental: Intervention Group
Sleep extension-based intervention focused on increasing time in bed by 2 hours per night.
Related Therapeutic Areas
Sponsors
Leads: University of Utah

This content was sourced from clinicaltrials.gov

Similar Clinical Trials